About: Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1995 (uk) article scientifique publié en 1995 (fr) im Dezember 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1995 (ast) scientific article published on 01 December 1995 (en)
publication date	wds:Q71523552-6325A733-FFC9-45EA-A474-2B198815E0E0
publication date	1995-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71523552-0069529D-8860-455E-9764-25D243DE27D7
language of work or name	English
author name string	wds:Q71523552-064A7498-12BF-45C1-B609-71C22DBFA75A wds:Q71523552-286B46B2-6E13-45D9-9E20-55ED44D172D9 wds:Q71523552-2E1592BD-57A7-4C4E-82EE-E576DE5B3A07 wds:Q71523552-48C1E13E-FFD9-47BF-B701-9EBCD08BDDB4 wds:Q71523552-6FFDE220-EC84-4D84-AE66-40F951574C89 wds:Q71523552-765DD31C-E419-41EA-910C-BC871C9D6512 wds:Q71523552-A5192A94-51A5-4832-925C-80D7A3EDB1C2 wds:Q71523552-B47377E0-CAE4-48AA-96D5-A12FDA2BC85E
author name string	Rubin M Kuritzkes DR Santana J Fallon MA Quinn JB MacArthur RD Jemsek J Benoit SL
rdfs:label	Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party (en) Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party (nl)
skos:prefLabel	Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party (en) Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party (nl)
name	Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party (en) Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party (nl)
author	wds:Q71523552-5C408835-2E57-49BB-B0E8-124D5C9A6E45
author	Joseph J Eron
title	wds:Q71523552-DCD3BEE3-E65C-401B-B43C-CDE4AB2187F6
title	Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party (en)
page(s)	wds:Q71523552-B8D5D07D-8E53-4CF7-AA80-52D2F63232F0
page(s)	1662-1669
instance of	wds:Q71523552-4DCE6741-70CB-4AC2-B535-C9223C7142BA
instance of	scholarly article
main subject	wds:Q71523552-48F69ED5-ED5C-4802-B712-A64CC8E66C7D wds:Q71523552-5C7CA188-4E4F-4622-8B16-987BBD99B2FF wds:Q71523552-6FA0124B-9851-4947-83F3-CB3C7E9DD15C
main subject	wd:Q198504 HIV wd:Q422631
PubMed ID	wds:Q71523552-00C98916-BC44-42DB-B8BC-6F636A2EF7DD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7477218
PubMed ID	7477218
published in	wds:Q71523552-5A779F07-86FF-4A3A-A3C6-2F3C758ACB6A
published in	The New England Journal of Medicine
issue	wds:Q71523552-8095AD4D-E988-477A-AD56-E2DFAAA3CA0F
volume	wds:Q71523552-D666CA66-489E-4CE6-8D75-16EAB0B720B3
issue	25
volume	333
DOI	wds:Q71523552-461CBEB9-53B0-4312-B5D9-01B70E6AA71D
DOI	http://dx.doi.org/10.1056/NEJM199512213332502
DOI	10.1056/NEJM199512213332502
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71523552
is cites work of	Pre-existence and emergence of drug resistance in HIV-1 infection. Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1 L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity? Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours Combination chemotherapy for human immunodeficiency virus-1. Risk and management of blood-borne infections in health care workers Biochemical mechanism of HIV-1 resistance to rilpivirine The critical role of p38 MAP kinase in T cell HIV-1 replication. A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapy Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials HIV-1 antiretroviral resistance: scientific principles and clinical applications Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection Natural history of HIV-1 infection Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma Converting cancer therapies into cures: lessons from infectious diseases HIV viral load markers in clinical practice The clinical utility of viral quantitation using molecular methods. A varying-coefficient method for analyzing longitudinal clinical trials data with nonignorable dropout The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group. Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults Antiretroviral drugs for AIDS. Recent advances in L-nucleosides: chemistry and biology The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro Antiretroviral therapy for human immunodeficiency virus infection in 1997.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software